These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

252 related articles for article (PubMed ID: 37246320)

  • 61. ASSOCIATION OF VITAMIN D WITH MILD COGNITIVE IMPAIRMENT AND ALZHEIMER'S DEMENTIA IN OLDER MEXICAN ADULTS.
    Aguilar-Navarro SG; Mimenza-Alvarado AJ; Jiménez-Castillo GA; Bracho-Vela LA; Yeverino-Castro SG; Ávila-Funes JA
    Rev Invest Clin; 2019; 71(6):381-386. PubMed ID: 31823966
    [TBL] [Abstract][Full Text] [Related]  

  • 62. Vitamin D Improves Neurogenesis and Cognition in a Mouse Model of Alzheimer's Disease.
    Morello M; Landel V; Lacassagne E; Baranger K; Annweiler C; Féron F; Millet P
    Mol Neurobiol; 2018 Aug; 55(8):6463-6479. PubMed ID: 29318446
    [TBL] [Abstract][Full Text] [Related]  

  • 63. Can Co-Activation of Nrf2 and Neurotrophic Signaling Pathway Slow Alzheimer's Disease?
    Murphy KE; Park JJ
    Int J Mol Sci; 2017 May; 18(6):. PubMed ID: 28561773
    [TBL] [Abstract][Full Text] [Related]  

  • 64. Nutritional antioxidants and the heme oxygenase pathway of stress tolerance: novel targets for neuroprotection in Alzheimer's disease.
    Calabrese V; Butterfield DA; Stella AM
    Ital J Biochem; 2003 Dec; 52(4):177-81. PubMed ID: 15141484
    [TBL] [Abstract][Full Text] [Related]  

  • 65. Antioxidant pathways in Alzheimer's disease: possibilities of intervention.
    Viña J; Lloret A; Giraldo E; Badia MC; Alonso MD
    Curr Pharm Des; 2011 Dec; 17(35):3861-4. PubMed ID: 21933145
    [TBL] [Abstract][Full Text] [Related]  

  • 66. Active form of vitamin D analogue mitigates neurodegenerative changes in Alzheimer's disease in rats by targeting Keap1/Nrf2 and MAPK-38p/ERK signaling pathways.
    Saad El-Din S; Rashed L; Medhat E; Emad Aboulhoda B; Desoky Badawy A; Mohammed ShamsEldeen A; Abdelgwad M
    Steroids; 2020 Apr; 156():108586. PubMed ID: 31982424
    [TBL] [Abstract][Full Text] [Related]  

  • 67. [Oxidative stress in the pathogenesis of Alzheimer's disease and antioxidant neuroprotection].
    Behl C; Holsboer F
    Fortschr Neurol Psychiatr; 1998 Mar; 66(3):113-21. PubMed ID: 9565761
    [TBL] [Abstract][Full Text] [Related]  

  • 68. Polyunsaturated Fatty Acids Mend Macrophage Transcriptome, Glycome, and Phenotype in the Patients with Neurodegenerative Diseases, Including Alzheimer's Disease.
    Dover M; Moseley T; Biskaduros A; Paulchakrabarti M; Hwang SH; Hammock B; Choudhury B; Kaczor-Urbanowicz KE; Urbanowicz A; Morselli M; Dang J; Pellegrini M; Paul K; Bentolila LA; Fiala M
    J Alzheimers Dis; 2023; 91(1):245-261. PubMed ID: 36373322
    [TBL] [Abstract][Full Text] [Related]  

  • 69. Oxidative modification of brain proteins in Alzheimer's disease: perspective on future studies based on results of redox proteomics studies.
    Sultana R; Butterfield DA
    J Alzheimers Dis; 2013; 33 Suppl 1():S243-51. PubMed ID: 22683528
    [TBL] [Abstract][Full Text] [Related]  

  • 70. Oxidatively modified proteins in Alzheimer's disease (AD), mild cognitive impairment and animal models of AD: role of Abeta in pathogenesis.
    Sultana R; Perluigi M; Butterfield DA
    Acta Neuropathol; 2009 Jul; 118(1):131-50. PubMed ID: 19288120
    [TBL] [Abstract][Full Text] [Related]  

  • 71. Future Therapeutic Perspectives into the Alzheimer's Disease Targeting the Oxidative Stress Hypothesis.
    Teixeira JP; de Castro AA; Soares FV; da Cunha EFF; Ramalho TC
    Molecules; 2019 Dec; 24(23):. PubMed ID: 31816853
    [TBL] [Abstract][Full Text] [Related]  

  • 72. Vitamin D and cognition: an update of the current evidence.
    Anastasiou CA; Yannakoulia M; Scarmeas N
    J Alzheimers Dis; 2014; 42 Suppl 3():S71-80. PubMed ID: 24820017
    [TBL] [Abstract][Full Text] [Related]  

  • 73. Effects of the superoxide dismutase/catalase mimetic EUK-207 in a mouse model of Alzheimer's disease: protection against and interruption of progression of amyloid and tau pathology and cognitive decline.
    Clausen A; Xu X; Bi X; Baudry M
    J Alzheimers Dis; 2012; 30(1):183-208. PubMed ID: 22406441
    [TBL] [Abstract][Full Text] [Related]  

  • 74. Verapamil attenuates scopolamine induced cognitive deficits by averting oxidative stress and mitochondrial injury - A potential therapeutic agent for Alzheimer's Disease.
    Ponne S; Kumar CR; Boopathy R
    Metab Brain Dis; 2020 Mar; 35(3):503-515. PubMed ID: 31691145
    [TBL] [Abstract][Full Text] [Related]  

  • 75. Vitamin C deficiency in the brain impairs cognition, increases amyloid accumulation and deposition, and oxidative stress in APP/PSEN1 and normally aging mice.
    Dixit S; Bernardo A; Walker JM; Kennard JA; Kim GY; Kessler ES; Harrison FE
    ACS Chem Neurosci; 2015 Apr; 6(4):570-81. PubMed ID: 25642732
    [TBL] [Abstract][Full Text] [Related]  

  • 76. Alzheimer's Disease is Driven by Intraneuronally Retained Beta-Amyloid Produced in the AD-Specific, βAPP-Independent Pathway: Current Perspective and Experimental Models for Tomorrow.
    Volloch V; Olsen B; Rits S
    Ann Integr Mol Med; 2020; 2(1):90-114. PubMed ID: 32617536
    [TBL] [Abstract][Full Text] [Related]  

  • 77. Evaluation of Mitochondrial Oxidative Stress in the Brain of a Transgenic Mouse Model of Alzheimer's Disease by in vitro Electron Paramagnetic Resonance Spectroscopy.
    Manabe T; Matsumura A; Yokokawa K; Saito T; Fujikura M; Iwahara N; Matsushita T; Suzuki S; Hisahara S; Kawamata J; Suzuki H; Emoto MC; Fujii HG; Shimohama S
    J Alzheimers Dis; 2019; 67(3):1079-1087. PubMed ID: 30714961
    [TBL] [Abstract][Full Text] [Related]  

  • 78. Vitamin D and Alzheimer's disease: is there a link?
    Pogge E
    Consult Pharm; 2010 Jul; 25(7):440-50. PubMed ID: 20601349
    [TBL] [Abstract][Full Text] [Related]  

  • 79. Delineation of Neuroprotective Effects and Possible Benefits of AntioxidantsTherapy for the Treatment of Alzheimer's Diseases by Targeting Mitochondrial-Derived Reactive Oxygen Species: Bench to Bedside.
    Walia V; Kaushik D; Mittal V; Kumar K; Verma R; Parashar J; Akter R; Rahman MH; Bhatia S; Al-Harrasi A; Karthika C; Bhattacharya T; Chopra H; Ashraf GM
    Mol Neurobiol; 2022 Jan; 59(1):657-680. PubMed ID: 34751889
    [TBL] [Abstract][Full Text] [Related]  

  • 80. Alzheimer's disease and oxidative stress: implications for novel therapeutic approaches.
    Behl C
    Prog Neurobiol; 1999 Feb; 57(3):301-23. PubMed ID: 10096843
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 13.